alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Mr. Brett Kruger 

Division Chief 

U.S. Air Carrier Licensing Division 

U.S. Department of Transportation 

1200 New Jersey Avenue, SE 

Washington, DC 20590 

Re: Application of Alaska Airlines, Inc. for Exemption (Docket DOT -O~T -2015-

0049) 

Dear Mr. Kruger: 

We have polled each of the U.S. air carrier representatives listed on the attached service 

list regarding the above-referenced application. Each of the carrier representatives has indicated 

that they have no objection to the Department's grant of the requested exemption authority. 

Sincerely, 

COZEN O'CONNOR 

Counsel for 

Alaska Airlines, Inc. 

16271 Street, NW Suite 1100 Washington, D.C. 20006 

202.912.4800 800.540.1355 202.861 .1905 Fax cozen.com 
Florida West Airlines: Frontier Airlines: 

Amerijet Int'l: 

Atlas Air: 

Centurion Air Cargo: 

Delta Air Lines: 

ExpressJet: 

Federal Aviation Administration: Federal Express: 

JetBlue: 

Kalitta Air: 

Polar Air Cargo: 

Southern Air: Southwest Airlines: 

Spirit Airlines: Sun Country Airlines: 

United Airlines: 

United Parcel Service: 

Virgin America: 

Dated: March 12, 2015 

robert. wirick@aa. com 

abigail.donovan@aa.com 

sandysinick@gmail.com 

howard.diamond@flyfrontier.com 

jcanny@amerijet.com 

rpommer@atlasair .com 

john@mietuslaw.com 

sascha. vanderbellen@del ta.com 

christopher. walker@del ta.com 

gmurphy@crowell.com 

john.s.duncan@faa.gov 

nssparks@fedex.com 

cefelts@fedex.com 

jhill@cooley .com 

perkmann@cooley .com psanderlin@kalittaair.com 

kevin.montgomery@polaraircargo.com 

agoerlich@ggh-airlaw.com 

bob.kneisley@wnco.com 

leslie.abbott@wnco.com 

jyoung@yklaw.com 

dkirstein@yklaw.com 

thomas. ting@suncountry .com 

dan. weiss@united.com 

steve.morrissey@united.com 

gmurphy@crowell.com 

anita.mosner@hklaw.com 

J ennifer.nowak@hklaw.com 

mlbenge@zsrlaw.com 

Kenneth C. Hines
**EXHIBIT        99.8**

 

|   | **PricewaterhouseCoopers LLP**

**Chartered Accountants**

PricewaterhouseCoopers Place

250 Howe Street, Suite 700

Vancouver, British Columbia

Canada V6C 3S7

Telephone +1 604 806 7000

Facsimile +1 604 806 7806

                          |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

**CONSENT OF INDEPENDENT ACCOUNTANTS**

 

We        hereby consent to the incorporation by reference in the Annual Report on Form 40-F of        Exeter Resource Corporation of our audit report dated March 28**,** 2008        relating to the financial statements as at and for the year ended December 31, 2007 and the        effectiveness of internal control over financial reporting as at December 31,        2007.

 

/s/        PricewaterhouseCoopers LLP

**Chartered Accountants**

Vancouver,        British Columbia

March 31,        2008

 

 

 

 

 

 

 

 

 

PricewaterhouseCoopers refers to the Canadian firm of PricewaterhouseCoopers        LLP and the other member firms of PricewaterhouseCoopers International Limited, each of        which is a separate and independent legal entity.

 

----
Trimble Navigation Limited Annual Management Incentive Plan Description



 EXHIBIT 10.1 
 Trimble Navigation Limited Annual Management Incentive Plan Description 
  

	1.	Definitions: 

  

	 	a.	“Company” means Trimble Navigation Limited, a California corporation. 

  

	 	b.	“Board of Directors” means the Board of Directors of the Company. 

  

	 	c.	“Operating Income” means (i) with respect to a division, operating income for that division and (ii) with respect to the Company, operating income for the
Company adjusted for amortization of intangibles, restructuring and infrequent charges. 

  

	2.	Participants: The CEO, all of the Vice Presidents of the Company and a number of senior-level managers and individual contributors as nominated by their respective Vice Presidents
and approved by the CEO of the Company. 

  

	3.	Payments earned under the Management Incentive Plan depend upon the Company’s quarterly and annual Operating Income, with minimum thresholds for revenue and Operating Income as
a percentage of revenue. 

  

	4.	Target payouts, ranging from 10% to 80% of base annual salary for each participant are determined by the CEO of the Company in conjunction with the executive officers and the vice
presidents of the Company, and approved by the Board of Directors. The Board of Directors has established an 80% target for the CEO. 

  

	5.	The payout under the Plan ranges from zero to 300% of each participant’s target, based upon achievement of each fiscal year’s planned operating income of a combination of
division and/or Company performance. Payments are made on a quarterly basis, 10% of target each quarter and the remainder after the close of the respective fiscal year. 

  

	6.	The Plan shall continue in effect, from year to year, until terminated or amended by the Board of Directors.
Regulatory Evaluation

Docket No. FAA-2015-4212 Directorate Identifier: 2015-NM-010-AD

If you make changes to the values in the table below, you must ensure the totals update accordingly. If 

they do not, click (or Tab) into and then out of the changed cell.

Estimated Costs:

Action

(e.g., Inspection, 

replacement)

Do not include oncondition costs here

Costs per Product (e.g., aircraft, engine, 

propeller, appliance)

Work-hours

(include 

access, testing, 

and close-up)

Labor 

cost 

(@$85/h

our)

Parts Cost Total Costs 

(labor + 

parts)

Number of 

U.S. 

Registered 

Products

Total Cost 

for U.S. Fleet

Revise 

maintenance/inspec

tion program

1.0 $ 85.00 $0 $ 85.00 4 $ 340.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

The known number of products in compliance:

Total Costs of compliance for U.S. fleet: $ 340

Costs covered under warranty (if known) $

On-Condition Costs:

Action

(e.g., Inspection, 

replacement)

Work-hours 

(include access, 

testing, and closeup)

Labor cost 

(@$85/hour)

Parts Cost Cost per Product

$ 0.00 $ 0.00

$ 0.00 $ 0.00

$ 0.00 $ 0.00

$ 0.00 $ 0.00

Special considerations for Economic Analysis (Use this field to explain anything in the Estimated Costs table 

that was assumed or might not be obvious. This field can also be used to explain warranty costs):
Executive Order 12866:

Could the AD be considered a “significant regulatory action”?

YES* NO 

*Explanation: 

DOT Regulatory Policies and Procedures:

Is the AD significant? 

YES* NO 

*Explanation: 

Regulatory Flexibility Act:

Will the AD have a significant economic impact on a substantial number of small entities? Explain for 

either a Yes or No answer.

YES NO 

Explanation: 

Intrastate Aviation in Alaska:

This AD could affect intrastate aviation in Alaska. Is it appropriate to include specific requirements for 

aircraft operated in Alaska where aviation might be the only mode of transportation?

YES* NO 

*Explanation:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### International Trade Administration

###### National Institutes of Standards and Technology

      ( print page 18351)    
This is a decision consolidated pursuant to Section 6(c) of the Educational, Scientific, and Cultural Materials Importation Act of 1966 (Pub. L. 89-651, as amended by Pub. L. 106-36; 80 Stat. 897; 15 CFR part 301). Related records can be viewed between 8:30 A.M. and 5:00 P.M. in Room 3705, U.S. Department of Commerce, 14th and Constitution Avenue., NW, Washington, D.C.

*Docket Number: 09-008.*                     Applicant: National Institutes of Standards and Technology, Gaithersburg, MD 20899. Instrument: Electron Microscope. Manufacturer: FEI Company, the Netherlands. Intended Use: See notice at 74 FR 16835, April 13, 2009.                 

Comments: None received. Decision: Approved. No instrument of equivalent scientific value to the foreign instrument, for such purposes as this instrument is intended to be used, is being manufactured in the United States at the time the instrument was ordered. Reasons: The foreign instrument is an electron microscope and is intended for research or scientific educational uses requiring an electron microscope. We know of no electron microscope, or any other instrument suited to this purpose, which is being manufactured in the United States at the time of order of this instrument.

Dated: April 16, 2009.

Christopher Cassel,

Acting Director, Subsidies Enforcement Office, Import Administration.

[FR Doc. E9-9235 Filed 4-21-09; 8:45 am]

BILLING CODE 3510-DS-S
EXHIBIT 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with NextMart, Inc.s (the Company) Annual Report on Form 10-K for the fiscal year ended September 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the Report),the undersigned officers of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Act of 1934; and  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  NextMart, Inc.  /s/ Menghua Liu Menghua Liu Chief Executive Officer Date: January 13, 2010  /s/ Carl Zhou Carla Zhou Chief Financial Officer Date January 13, 2010
C OURT OF A PPEALS FOR THE
F IRST D ISTRICT OF T EXAS AT H OUSTON

O RDER

Appellate case name: In re American Fisheries, Inc. , Relator

Appellate case number: 01

- 1 7

- 00 0 26

- CV

Trial court case number: 2013

- 29749

Trial court: 1 57 th District Court of Harris County

On January 11 , 201 7

, r elator

, American Fisheries, Inc., filed a petition for writ of mandamus seeking to vacate the respondent trial judge’s October 21 , 2016 order quashing the depositions on written questions propounded by relator to Zong Dao Shao, Feng Shao, Sizhong Ge, and Jiahua Ma, and the November 11, 201 6 order denying

relator’ s motion for reconsideration of the prior order

. A lthough relator ’s p etition refers to a transcript of the November 11, 2016 hearing and several mandamus record tabs, it

failed to file those records. Thus, th e Court ORDER S relator

, within 10 days of the date of this order, to file a supplemental mandamus record containing the November 11, 2016 hearing and th e remainder of the record tabs

. See T EX

. R. A PP

. P. 52. 7 ( a), (b).

With the petition, relator a l s o filed a n emergency motion for temporary relief seeking a stay of the February 6, 2017 trial pending disposition of this petition, with the required certificate of compliance. See T EX

. R. A PP

. P. 52.10(a). Accordingly, the Court
grant s the relator’ s motion and ORDER S that the February 6, 2017 trial is stayed

. See

T EX

. R. A PP

. P. 52.10(b). This stay is effective until the mandamus petition in this Court is finally decided or this Court otherwise orders the stay lifted. See id. Any party may

file a motion for recons ideration of the stay. See id. 52.10(c).

Finally, t he Court requests a response to the petition for writ of mandamus by any real party in interest. See T EX

. R. A PP

. P. 52. 8(b)(1)

. The response, if any, shall be filed

within 2 0 days from the date of this order

. See id. 2, 52.4

.
It is so ORDERED.

Judge’s signature: /s/ Evelyn V. Keyes

 Acting individually  Acting for the Court

Date: January 1 9 , 2017
Unassociated Document




Exhibit 4.8.36 - Electronic Catalogue (12) – Cold Storage - Specification of Cold Storage - Structural Plan for Bottom Bracket of Cold Storage
Order entered March 17, 2020

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-20-00277-CR

No. 05-20-00285-CR

No. 05-20-00286-CR

UMAIR AHMAE KHAN, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 199th Judicial District Court

Collin County, Texas

Trial Court Cause Nos. 199-80965-2018, 199-81674-2018 & 199-83132-2018

ORDER

We REINSTATE these appeals. 

We abated for a hearing on counsel. On March 10, 2020, the Court was 

informed appellant hired James P. Whalen as retained counsel. We DIRECT the 

Clerk to list James P. Whalen as counsel for appellant. All future correspondence 

should be sent to Mr. Whalen at the address listed in our records.

The appellate record is due April 13, 2020. 
We DIRECT the Clerk to send copies of this order to the Honorable Angela 

Tucker, Presiding Judge, 199th Judicial District Court; Lynne Finley, Collin 

County District Clerk; LaTresta Ginyard, official court reporter, 199th Judicial 

District Court; James P. Whalen; and the Collin County District Attorney’s Office.

/s/ LANA MYERS 

JUSTICE
##### 



[ * ] = Certain information on this page has been redacted and filed separately with the Securities and Exchange
Commission. Confidential treatment has been requested with respect to the omitted portions.
 EXHIBIT 10.65
    
 RE:
    
    Amendment No. 3 to the Drug Discovery Collaboration Agreement(Amendment No. 3)
  InterMune Array Agreement
 Amendment Effective Date
 1.
    
    Section 2.3 of the Agreement is amended in its entirety to read as follows:2.3 Term and Termination of Research Collaboration. The Research Collaboration
shall commence on the Effective Date and shall end upon the first to occur of (i) June 30,
2005, (ii) the termination of this Agreement, or (iii) [ * ] after written notice from
InterMune that InterMune elects (in its sole discretion) to early terminate the Research
Collaboration (such period beginning on the Effective Date and ending upon the earliest of
(i), (ii) and (iii), the Research Term). InterMune shall have the right to extend
the Research Term for additional six-month periods after June 30, 2005 on the same terms and
conditions as previously conducted. To exercise such right, InterMune shall provide written
notice to Array on or before the date ninety (90) days before the end of any such six-month
period.2.
    
    The Joint Research Committee shall work together to produce a new Exhibit A Research
Plan pursuant to Article 3 of the Agreement as soon as practicable after the execution of this
Amendment No. 3.




---



##### 



Acknowledged and Agreed:
 ARRAY BIOPHARMA, INC.
 By:
    
    /s/ David L. SnitmanName:
    
    David L. SnitmanTitle:
    
    COODate:
    
    1-15-04
 [ * ] = Certain information on this page has been redacted and filed separately with the Securities and Exchange
Commission. Confidential treatment has been requested with respect to the omitted portions.
 2




---



##### 



[ * ] = Certain information on this page has been redacted and filed separately with the Securities and Exchange
Commission. Confidential treatment has been requested with respect to the omitted portions.
 3
**Exhibit 10.11**

** **

**Compensation of Directors**

 

Directors who are not officers or employees of ourgeneral partner will receive (a) a $25,000 annual cash retainer fee, (b) $1,500for each regularly scheduled meeting attended, (c) $750 for each specialmeeting attended and (d) awards under our Long-Term Incentive Plan. Inaddition to the foregoing, each director who serves on a committee will receive$1,000 for each committee meeting attended, the chairman of our audit committeewill receive an annual retainer of $5,000 and the chairmen of our othercommittees will receive an annual retainer of $2,500. In addition, eachnon-employee director will be reimbursed for his out-of-pocket expenses inconnection with attending meetings of the board of directors or committees. Eachdirector will be fully indemnified by us for his actions associated with beinga director to the fullest extent permitted under Delaware law.

 

----
Opinion filed January 15, 2015

In The

Eleventh Court of Appeals ___________

No. 11-14-00107-CV

___________

COVE MINI STORAGE, INC.; GORDON MICKAN; MARCUS 

MICKAN; KEN CRAIG AND AMYE CRAIG AS TRUSTEES OF 

THE KEN AND AMYE CRAIG TRUST; KEN CRAIG; AND 

AMYE CRAIG, Appellants

V.

FIRST AMERICAN TITLE INSURANCE COMPANY, Appellee

On Appeal from the 91st District Court

Eastland County, Texas

Trial Court Cause No. CV-1042068A

M E M O R A N D U M O P I N I O N

Appellants have filed in this court an unopposed motion for dismissal with 

prejudice. In the motion, Appellants “move for dismissal with prejudice of this 

lawsuit.” In accordance with Appellants’ request to dismiss this lawsuit, we 

dismiss their appeal. See TEX. R. APP. P. 42.1(a)(1).
2

The motion is granted, and the appeal is dismissed.

PER CURIAM

January 15, 2015

Panel consists of: Wright, C.J.,

Willson, J., and Bailey, J.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2960 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2960

             To suspend temporarily the duty on Profenofos.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2012

 Ms. Klobuchar introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
             To suspend temporarily the duty on Profenofos.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PROFENOFOS.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      O-(4-bromo-2-       Free         No change        No change        On or before 12/  ''.
                        chlorophenyl)-O-                                                   31/2015.......
                        ethyl-s-propyl
                        phosphorothioate
                        (Profenofos) (CAS
                        No. 41198-08-7)
                        (provided for in
                        subheading
                        2930.90.10)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2988 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2988

To suspend temporarily the duty on tetrakis(hydroxymethyl) phosphonium 
                                sulfate.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2012

 Mr. Menendez introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To suspend temporarily the duty on tetrakis(hydroxymethyl) phosphonium 
                                sulfate.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. TETRAKIS(HYDROXYMETHYL) PHOSPHONIUM SULFATE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Tetrakis(hydroxyme  Free         No change        No change        On or before 12/  ''.
                        thyl) phosphonium                                                  31/2015.......
                        sulfate (THPS)
                        (CAS No. 55566-30-
                        8) (provided for
                        in subheading
                        2931.00.90)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Exhibit 32.1
                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Geotec Thermal Generators, Inc. (the
"Company") on Form 10-KSB for the fiscal year ended December 31, 2003 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, W. Richard Lueck, Chief Executive Officer and Accounting Officer
of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to
ss.906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.





/s/ W. Richard Lueck
---------------------------------
    W. Richard Lueck
    CEO, Secretary and Treasurer
    Principal Executive Financial
    and Accounting Officer